Global Longevity and Anti-senescence Therapy Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	201 Pages	TechNavio	December, 2024	INF19463342

Best Price Guarantee
Price	from $2,500
Length	201 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463342

Longevity And Anti-Senescence Therapy Market 2025-2029

The longevity and anti-senescence therapy market is forecasted to grow by USD 9.5 bn during 2024-2029, accelerating at a CAGR of 5.2% during the forecast period. The report on the longevity and anti-senescence therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing elderly population, rising disposable income, and focus on research and development.

Technavio's longevity and anti-senescence therapy market is segmented as below:

By Therapy

Gene therapy
Immunotherapy
Senolytic drug therapy

By Application

Cancer
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic partnerships and collaborations as one of the prime reasons driving the longevity and anti-senescence therapy market growth during the next few years. Also, ai integration for accelerated age-related drug development and emphasis on regenerative medicine will lead to sizable demand in the market.

The report on the longevity and anti-senescence therapy market covers the following areas:

Longevity And Anti-Senescence Therapy Market sizing
Longevity And Anti-Senescence Therapy Market forecast
Longevity And Anti-Senescence Therapy Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading longevity and anti-senescence therapy market vendors that include AbbVie Inc., Altos Labs Inc., Bayer AG, BioViva USA Inc, Bristol Myers Squibb Co., ChromaDex Inc., Elixirgen Therapeutics Inc., Elysium Health Inc., Forever Labs, Fountain Therapeutics, GlaxoSmithKline Plc, Insilico Medicine, Juvenescence, Kolon TissueGene Inc., Life Biosciences Inc., Merck and Co. Inc., Novartis AG, Oisin Biotechnologies, Pfizer Inc., and Rejuvenate Biomed NV. Also, the longevity and anti-senescence therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Therapy; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Longevity And Anti-Senescence Therapy Market 2019 - 2023; Historic Market Size - Data Table on Global Longevity And Anti-Senescence Therapy Market 2019 - 2023 ($ billion); 5.2 Therapy segment analysis 2019 - 2023; Historic Market Size - Therapy Segment 2019 - 2023 ($ billion); 5.3 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ billion); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 The AI impct on Global Longevity and Anti-senescence Therapy Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapy: 8.1 Market segments; Chart on Therapy - Market share 2024-2029 (%); Data Table on Therapy - Market share 2024-2029 (%); 8.2 Comparison by Therapy; Chart on Comparison by Therapy; Data Table on Comparison by Therapy; 8.3 Gene therapy - Market size and forecast 2024-2029; Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion); Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion); Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); 8.4 Immunotherapy - Market size and forecast 2024-2029; Chart on Immunotherapy - Market size and forecast 2024-2029 ($ billion); Data Table on Immunotherapy - Market size and forecast 2024-2029 ($ billion); Chart on Immunotherapy - Year-over-year growth 2024-2029 (%); Data Table on Immunotherapy - Year-over-year growth 2024-2029 (%); 8.5 Senolytic drug therapy - Market size and forecast 2024-2029; Chart on Senolytic drug therapy - Market size and forecast 2024-2029 ($ billion); Data Table on Senolytic drug therapy - Market size and forecast 2024-2029 ($ billion); Chart on Senolytic drug therapy - Year-over-year growth 2024-2029 (%); Data Table on Senolytic drug therapy - Year-over-year growth 2024-2029 (%); 8.6 Market opportunity by Therapy; Market opportunity by Therapy ($ billion); Data Table on Market opportunity by Therapy ($ billion)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Cancer - Market size and forecast 2024-2029; Chart on Cancer - Market size and forecast 2024-2029 ($ billion); Data Table on Cancer - Market size and forecast 2024-2029 ($ billion); Chart on Cancer - Year-over-year growth 2024-2029 (%); Data Table on Cancer - Year-over-year growth 2024-2029 (%); 9.4 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.9 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.10 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.11 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.12 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 11.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.14 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.15 Australia - Market size and forecast 2024-2029; Chart on Australia - Market size and forecast 2024-2029 ($ billion); Data Table on Australia - Market size and forecast 2024-2029 ($ billion); Chart on Australia - Year-over-year growth 2024-2029 (%); Data Table on Australia - Year-over-year growth 2024-2029 (%); 11.16 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 14.5 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 14.6 BioViva USA Inc; BioViva USA Inc - Overview; BioViva USA Inc - Product / Service; BioViva USA Inc - Key offerings; SWOT; 14.7 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 14.8 Elixirgen Therapeutics Inc.; Elixirgen Therapeutics Inc. - Overview; Elixirgen Therapeutics Inc. - Product / Service; Elixirgen Therapeutics Inc. - Key offerings; SWOT; 14.9 Elysium Health Inc.; Elysium Health Inc. - Overview; Elysium Health Inc. - Product / Service; Elysium Health Inc. - Key offerings; SWOT; 14.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 14.11 Insilico Medicine; Insilico Medicine - Overview; Insilico Medicine - Product / Service; Insilico Medicine - Key offerings; SWOT; 14.12 Juvenescence; Juvenescence - Overview; Juvenescence - Product / Service; Juvenescence - Key offerings; SWOT; 14.13 Kolon TissueGene Inc.; Kolon TissueGene Inc. - Overview; Kolon TissueGene Inc. - Product / Service; Kolon TissueGene Inc. - Key offerings; SWOT; 14.14 Life Biosciences Inc.; Life Biosciences Inc. - Overview; Life Biosciences Inc. - Product / Service; Life Biosciences Inc. - Key offerings; SWOT; 14.15 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 14.16 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 14.17 Oisin Biotechnologies; Oisin Biotechnologies - Overview; Oisin Biotechnologies - Product / Service; Oisin Biotechnologies - Key offerings; SWOT; 14.18 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Longevity And Anti-Senescence Therapy Market 2019 - 2023 ($ billion); Exhibits25: Historic Market Size - Therapy Segment 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Therapy - Market share 2024-2029 (%); Exhibits37: Data Table on Therapy - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Therapy; Exhibits39: Data Table on Comparison by Therapy; Exhibits40: Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits41: Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits42: Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Immunotherapy - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on Immunotherapy - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on Immunotherapy - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Immunotherapy - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Senolytic drug therapy - Market size and forecast 2024-2029 ($ billion); Exhibits49: Data Table on Senolytic drug therapy - Market size and forecast 2024-2029 ($ billion); Exhibits50: Chart on Senolytic drug therapy - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Senolytic drug therapy - Year-over-year growth 2024-2029 (%); Exhibits52: Market opportunity by Therapy ($ billion); Exhibits53: Data Table on Market opportunity by Therapy ($ billion); Exhibits54: Chart on Application - Market share 2024-2029 (%); Exhibits55: Data Table on Application - Market share 2024-2029 (%); Exhibits56: Chart on Comparison by Application; Exhibits57: Data Table on Comparison by Application; Exhibits58: Chart on Cancer - Market size and forecast 2024-2029 ($ billion); Exhibits59: Data Table on Cancer - Market size and forecast 2024-2029 ($ billion); Exhibits60: Chart on Cancer - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Cancer - Year-over-year growth 2024-2029 (%); Exhibits62: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits63: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits64: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits66: Market opportunity by Application ($ billion); Exhibits67: Data Table on Market opportunity by Application ($ billion); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits78: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits79: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits82: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits83: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits90: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits91: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits94: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits95: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits98: Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits99: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Australia - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on Australia - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on Australia - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Australia - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits129: Market opportunity By Geographical Landscape ($ billion); Exhibits130: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits131: Impact of drivers and challenges in 2024 and 2029; Exhibits132: Overview on criticality of inputs and factors of differentiation; Exhibits133: Overview on factors of disruption; Exhibits134: Impact of key risks on business; Exhibits135: Companies covered; Exhibits136: Company ranking index; Exhibits137: Matrix on companies position and classification; Exhibits138: AbbVie Inc. - Overview; Exhibits139: AbbVie Inc. - Product / Service; Exhibits140: AbbVie Inc. - Key news; Exhibits141: AbbVie Inc. - Key offerings; Exhibits142: SWOT; Exhibits143: Bayer AG - Overview; Exhibits144: Bayer AG - Business segments; Exhibits145: Bayer AG - Key news; Exhibits146: Bayer AG - Key offerings; Exhibits147: Bayer AG - Segment focus; Exhibits148: SWOT; Exhibits149: BioViva USA Inc - Overview; Exhibits150: BioViva USA Inc - Product / Service; Exhibits151: BioViva USA Inc - Key offerings; Exhibits152: SWOT; Exhibits153: Bristol Myers Squibb Co. - Overview; Exhibits154: Bristol Myers Squibb Co. - Product / Service; Exhibits155: Bristol Myers Squibb Co. - Key news; Exhibits156: Bristol Myers Squibb Co. - Key offerings; Exhibits157: SWOT; Exhibits158: Elixirgen Therapeutics Inc. - Overview; Exhibits159: Elixirgen Therapeutics Inc. - Product / Service; Exhibits160: Elixirgen Therapeutics Inc. - Key offerings; Exhibits161: SWOT; Exhibits162: Elysium Health Inc. - Overview; Exhibits163: Elysium Health Inc. - Product / Service; Exhibits164: Elysium Health Inc. - Key offerings; Exhibits165: SWOT; Exhibits166: GlaxoSmithKline Plc - Overview; Exhibits167: GlaxoSmithKline Plc - Business segments; Exhibits168: GlaxoSmithKline Plc - Key news; Exhibits169: GlaxoSmithKline Plc - Key offerings; Exhibits170: GlaxoSmithKline Plc - Segment focus; Exhibits171: SWOT; Exhibits172: Insilico Medicine - Overview; Exhibits173: Insilico Medicine - Product / Service; Exhibits174: Insilico Medicine - Key offerings; Exhibits175: SWOT; Exhibits176: Juvenescence - Overview; Exhibits177: Juvenescence - Product / Service; Exhibits178: Juvenescence - Key offerings; Exhibits179: SWOT; Exhibits180: Kolon TissueGene Inc. - Overview; Exhibits181: Kolon TissueGene Inc. - Product / Service; Exhibits182: Kolon TissueGene Inc. - Key offerings; Exhibits183: SWOT; Exhibits184: Life Biosciences Inc. - Overview; Exhibits185: Life Biosciences Inc. - Product / Service; Exhibits186: Life Biosciences Inc. - Key offerings; Exhibits187: SWOT; Exhibits188: Merck and Co. Inc. - Overview; Exhibits189: Merck and Co. Inc. - Business segments; Exhibits190: Merck and Co. Inc. - Key news; Exhibits191: Merck and Co. Inc. - Key offerings; Exhibits192: Merck and Co. Inc. - Segment focus; Exhibits193: SWOT; Exhibits194: Novartis AG - Overview; Exhibits195: Novartis AG - Business segments; Exhibits196: Novartis AG - Key news; Exhibits197: Novartis AG - Key offerings; Exhibits198: Novartis AG - Segment focus; Exhibits199: SWOT; Exhibits200: Oisin Biotechnologies - Overview; Exhibits201: Oisin Biotechnologies - Product / Service; Exhibits202: Oisin Biotechnologies - Key offerings; Exhibits203: SWOT; Exhibits204: Pfizer Inc. - Overview; Exhibits205: Pfizer Inc. - Product / Service; Exhibits206: Pfizer Inc. - Key news; Exhibits207: Pfizer Inc. - Key offerings; Exhibits208: SWOT; Exhibits209: Inclusions checklist; Exhibits210: Exclusions checklist; Exhibits211: Currency conversion rates for US$; Exhibits212: Research methodology; Exhibits213: Information sources; Exhibits214: Data validation; Exhibits215: Validation techniques employed for market sizing; Exhibits216: Data synthesis; Exhibits217: 360 degree market analysis; Exhibits218: List of abbreviations